Real-world evaluation of an acceptance and commitment therapy-based group programme for breast cancer survivors with fear of cancer recurrence.
Acceptance and commitment therapy
Breast cancer
Fear of cancer recurrence
Group support
Patient support
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
15 Nov 2023
15 Nov 2023
Historique:
received:
03
03
2023
accepted:
09
11
2023
medline:
16
11
2023
pubmed:
15
11
2023
entrez:
15
11
2023
Statut:
epublish
Résumé
To evaluate the effectiveness and acceptability of a 6-week acceptance and commitment therapy (ACT)-based group programme on participants' fear of cancer recurrence (FCR), quality of life (QoL), psychological distress and psychological flexibility at the end of the programme and 12-week follow-up. A one-group, post-test service evaluation of a real-world psychological programme was carried out to evaluate collected outcome measures and attendance for a total of 21 groups facilitated between 2017 and 2019. Participants were breast cancer survivors who attended a 6-week group programme led by NHS clinicians. Descriptive statistics and repeated measures ANOVA analyses were carried out for each outcome measure. Attendance levels were examined to assess acceptability. A total of 97 group participants who had completed curative treatment for breast cancer took part. Of whom, 89% completed at least 4 of the 6 weekly group sessions and 76% attended the 12-week follow-up session. Eighty-four (87%) participants returned outcome measures at all three time points relative to group participation (T1 = pre, T2 = post T3 = 12-week follow-up). Group participants were female, mean age 51.9 years. FCR was highest at T1 (mean 25.2, SD 4.7), reduced T2 (mean 21.2, SD 5.4) and further lowered T3 (mean 19.5, SD 6.2). This difference was statistically significant (p < 0.001). QoL was lowest at T1 (mean 62.4, SD 15.7), increased T2 (mean 71.7, SD 18.1) and further increased at T3 (mean 75.9, SD 17.5). This difference was statistically significant (p < 0.001). Psychological distress measures were shown to reduce, and psychological flexibility increased. This real-world evaluation of an ACT-based group programme led to improvements in FCR, QoL, psychological distress and psychological flexibility in this population. This evaluation provides basis for further investigation to determine if these results can be replicated by controlled research design across diverse populations.
Identifiants
pubmed: 37966674
doi: 10.1007/s00520-023-08179-3
pii: 10.1007/s00520-023-08179-3
pmc: PMC10651702
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
700Subventions
Organisme : Breast Cancer 2000
ID : SC030630
Organisme : Breast Cancer 2000
ID : SC030630
Organisme : Breast Cancer 2000
ID : SC030630
Organisme : Beatson Cancer Charity
ID : SC044442
Organisme : Beatson Cancer Charity
ID : SC044442
Organisme : Beatson Cancer Charity
ID : SC044442
Organisme : Beatson Cancer Charity
ID : SC044442
Informations de copyright
© 2023. The Author(s).
Références
J Contextual Behav Sci. 2022 Apr;24:185-196
pubmed: 36578359
Front Psychol. 2021 Jun 07;12:661190
pubmed: 34163405
Behav Res Ther. 2022 Jan;148:103995
pubmed: 34800873
Support Care Cancer. 2019 Nov;27(11):4055-4067
pubmed: 31286237
J Clin Oncol. 1997 Mar;15(3):974-86
pubmed: 9060536
J Natl Cancer Inst. 2022 Mar 8;114(3):391-399
pubmed: 34747484
Behav Res Ther. 2006 Jan;44(1):1-25
pubmed: 16300724
Support Care Cancer. 2016 Aug;24(8):3265-8
pubmed: 27169703
J Natl Cancer Inst. 2021 Nov 2;113(11):1442-1443
pubmed: 34057468
Support Care Cancer. 2012 Nov;20(11):2651-9
pubmed: 22328003
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Psychooncology. 2022 Jun;31(6):879-892
pubmed: 35388525
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Cancer Surviv. 2022 Jul 25;:
pubmed: 35876964
Psychother Psychosom. 2016;85(5):289-96
pubmed: 27508418
J Clin Oncol. 2019 Nov 1;37(31):2899-2915
pubmed: 31532725
Pilot Feasibility Stud. 2022 Aug 10;8(1):177
pubmed: 35948952
J Cancer Surviv. 2015 Sep;9(3):481-91
pubmed: 25603948
J Cancer Surviv. 2019 Oct;13(5):695-702
pubmed: 31347010
Curr Opin Oncol. 2022 Jul 1;34(4):279-284
pubmed: 35730523
Front Psychol. 2021 Mar 22;12:636933
pubmed: 33828505
J Oncol Pract. 2019 Sep;15(9):e787-e797
pubmed: 31298966
Front Psychol. 2021 Feb 22;12:640866
pubmed: 33692731
Psychol Res Behav Manag. 2020 Dec 21;13:1257-1268
pubmed: 33376421
Front Psychol. 2019 Jun 12;10:1302
pubmed: 31249541
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Front Psychiatry. 2019 Aug 07;10:537
pubmed: 31447709
J Clin Oncol. 2017 Dec 20;35(36):4066-4077
pubmed: 29095681
Cancer. 2020 Jan 1;126(1):211-218
pubmed: 31539169
Support Care Cancer. 2021 Dec;29(12):7647-7657
pubmed: 34137933
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10
pubmed: 35561298